The phase 2 human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to begin today.
from NDTV News - Special https://ift.tt/2FN96yE
Subscribe to:
Post Comments (Atom)
Microsoft-backed cloud platform ‘will bully Indians to agree with it’: Ola CEO
Bhavish Aggarwal, the founder and CEO of Ola, announced the company's move to shift its workloads from Microsoft's Azure to its prop...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
-
Trading in stock markets this week will be majorly influenced by the upcoming quarterly earnings from IT majors TCS and Infosys, along with...
No comments:
Post a Comment